Regeneron Pharmaceuticals
REGN
#260
Rank
A$118.44 B
Marketcap
$1,083
Share price
-1.37%
Change (1 day)
-27.18%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $56.24

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $59.92. In 2022 the company made an earnings per share (EPS) of $64.99 a decrease over its 2021 EPS that were of $122.62.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$56.24-13.47%
2022$64.99-47%
2021$122.62133.36%
2020$52.5469.13%
2019$31.07-14.44%
2018$36.31100.71%
2017$18.0931.78%
2016$13.7338.96%
2015$9.8872.55%
2014$5.73-17.55%
2013$6.94-44.98%
2012$12.62-422.54%
2011-$3.9192.13%
2010-$2.0449.41%
2009-$1.36-15.84%
2008-$1.62-36.88%
2007-$2.57-9.6%
2006-$2.844.12%
2005-$2.73-323.68%
2004$1.22-135.51%
2003-$3.43-24.38%
2002-$4.5456.35%
2001-$2.90187.3%
2000-$1.01-16%
1999-$1.20177.78%
1998-$0.43-35.71%
1997-$0.67-68.42%
1996-$2.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.70-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.59-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.61-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.59-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.00-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.10-91.49%๐Ÿ‡ซ๐Ÿ‡ท France